The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Functional plasticity of putative TP53 gain of function mutations in human gastrointestinal tract adenocarcinomas.
 
David R. Braxton
Honoraria - Caris Life Sciences; Caris Life Sciences
Research Funding - Deep Lens
Travel, Accommodations, Expenses - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Bayer; D&D Pharmatech; D&D Pharmatech; D&D Pharmatech; Loxo; Morphotek; Tarmeta Biosciences
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences
 
Sourat Darabi
Honoraria - OncoLens
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Michael J. Demeure
Consulting or Advisory Role - Avant Diagnostics; Bayer; Loxo/Lilly; Orphagen Pharmaceuticals; TD2
(OPTIONAL) Uncompensated Relationships - transmed7
 
Burton Larry Eisenberg
No Relationships to Disclose